nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2B6—Irinotecan—stomach cancer	0.131	0.217	CbGbCtD
Carbinoxamine—CYP2C9—Capecitabine—stomach cancer	0.112	0.186	CbGbCtD
Carbinoxamine—CYP2C8—Fluorouracil—stomach cancer	0.0955	0.158	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—stomach cancer	0.0718	0.119	CbGbCtD
Carbinoxamine—CYP2C9—Fluorouracil—stomach cancer	0.0666	0.11	CbGbCtD
Carbinoxamine—CYP3A4—Irinotecan—stomach cancer	0.0404	0.0668	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—stomach cancer	0.0347	0.0574	CbGbCtD
Carbinoxamine—CYP3A4—Docetaxel—stomach cancer	0.0296	0.0489	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—stomach cancer	0.022	0.0365	CbGbCtD
Carbinoxamine—Euphoric mood—Floxuridine—stomach cancer	0.00829	0.0299	CcSEcCtD
Carbinoxamine—Photosensitivity—Floxuridine—stomach cancer	0.00798	0.0287	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Floxuridine—stomach cancer	0.00553	0.0199	CcSEcCtD
Carbinoxamine—Agranulocytosis—Floxuridine—stomach cancer	0.00504	0.0182	CcSEcCtD
Carbinoxamine—Chest tightness—Docetaxel—stomach cancer	0.00485	0.0175	CcSEcCtD
Carbinoxamine—Chest tightness—Capecitabine—stomach cancer	0.0047	0.0169	CcSEcCtD
Carbinoxamine—Drowsiness—Mitomycin—stomach cancer	0.00424	0.0153	CcSEcCtD
Carbinoxamine—Confusional state—Floxuridine—stomach cancer	0.00347	0.0125	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Floxuridine—stomach cancer	0.00337	0.0121	CcSEcCtD
Carbinoxamine—Anorexia—Floxuridine—stomach cancer	0.00328	0.0118	CcSEcCtD
Carbinoxamine—Vision blurred—Mitomycin—stomach cancer	0.00312	0.0112	CcSEcCtD
Carbinoxamine—Neuritis—Docetaxel—stomach cancer	0.00305	0.011	CcSEcCtD
Carbinoxamine—Decreased appetite—Floxuridine—stomach cancer	0.00299	0.0108	CcSEcCtD
Carbinoxamine—Feeling abnormal—Floxuridine—stomach cancer	0.00284	0.0102	CcSEcCtD
Carbinoxamine—Confusional state—Mitomycin—stomach cancer	0.00272	0.00981	CcSEcCtD
Carbinoxamine—Euphoric mood—Fluorouracil—stomach cancer	0.00271	0.00975	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Mitomycin—stomach cancer	0.00265	0.00953	CcSEcCtD
Carbinoxamine—Extrasystoles—Capecitabine—stomach cancer	0.00262	0.00942	CcSEcCtD
Carbinoxamine—Photosensitivity—Fluorouracil—stomach cancer	0.0026	0.00938	CcSEcCtD
Carbinoxamine—Anorexia—Mitomycin—stomach cancer	0.00258	0.00928	CcSEcCtD
Carbinoxamine—Chest discomfort—Docetaxel—stomach cancer	0.00257	0.00926	CcSEcCtD
Carbinoxamine—Chest discomfort—Capecitabine—stomach cancer	0.00249	0.00896	CcSEcCtD
Carbinoxamine—Asthenia—Floxuridine—stomach cancer	0.00247	0.0089	CcSEcCtD
Carbinoxamine—Somnolence—Mitomycin—stomach cancer	0.0024	0.00865	CcSEcCtD
Carbinoxamine—Diarrhoea—Floxuridine—stomach cancer	0.00236	0.00849	CcSEcCtD
Carbinoxamine—Decreased appetite—Mitomycin—stomach cancer	0.00235	0.00846	CcSEcCtD
Carbinoxamine—Fatigue—Mitomycin—stomach cancer	0.00233	0.00839	CcSEcCtD
Carbinoxamine—Feeling abnormal—Mitomycin—stomach cancer	0.00223	0.00802	CcSEcCtD
Carbinoxamine—Vomiting—Floxuridine—stomach cancer	0.00219	0.00789	CcSEcCtD
Carbinoxamine—Irritability—Fluorouracil—stomach cancer	0.00218	0.00786	CcSEcCtD
Carbinoxamine—Headache—Floxuridine—stomach cancer	0.00216	0.00777	CcSEcCtD
Carbinoxamine—Neuritis—Epirubicin—stomach cancer	0.00205	0.0074	CcSEcCtD
Carbinoxamine—Nausea—Floxuridine—stomach cancer	0.00205	0.00737	CcSEcCtD
Carbinoxamine—Sweating increased—Irinotecan—stomach cancer	0.00201	0.00724	CcSEcCtD
Carbinoxamine—Asthenia—Mitomycin—stomach cancer	0.00194	0.00698	CcSEcCtD
Carbinoxamine—Neuritis—Doxorubicin—stomach cancer	0.0019	0.00685	CcSEcCtD
Carbinoxamine—Diarrhoea—Mitomycin—stomach cancer	0.00185	0.00666	CcSEcCtD
Carbinoxamine—Photosensitivity—Capecitabine—stomach cancer	0.00182	0.00656	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Fluorouracil—stomach cancer	0.0018	0.0065	CcSEcCtD
Carbinoxamine—Dizziness—Mitomycin—stomach cancer	0.00179	0.00644	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Capecitabine—stomach cancer	0.00177	0.00638	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Fluorouracil—stomach cancer	0.00173	0.00622	CcSEcCtD
Carbinoxamine—Vomiting—Mitomycin—stomach cancer	0.00172	0.00619	CcSEcCtD
Carbinoxamine—Headache—Mitomycin—stomach cancer	0.00169	0.0061	CcSEcCtD
Carbinoxamine—Agranulocytosis—Fluorouracil—stomach cancer	0.00164	0.00592	CcSEcCtD
Carbinoxamine—Nausea—Mitomycin—stomach cancer	0.00161	0.00578	CcSEcCtD
Carbinoxamine—Diplopia—Capecitabine—stomach cancer	0.0016	0.00576	CcSEcCtD
Carbinoxamine—Irritability—Capecitabine—stomach cancer	0.00153	0.00549	CcSEcCtD
Carbinoxamine—Urinary retention—Capecitabine—stomach cancer	0.00152	0.00547	CcSEcCtD
Carbinoxamine—Chills—Irinotecan—stomach cancer	0.00148	0.00534	CcSEcCtD
Carbinoxamine—Photosensitivity—Methotrexate—stomach cancer	0.00135	0.00488	CcSEcCtD
Carbinoxamine—Sweating increased—Capecitabine—stomach cancer	0.00135	0.00485	CcSEcCtD
Carbinoxamine—Vision blurred—Fluorouracil—stomach cancer	0.0013	0.00468	CcSEcCtD
Carbinoxamine—Vertigo—Irinotecan—stomach cancer	0.00129	0.00465	CcSEcCtD
Carbinoxamine—Photosensitivity—Epirubicin—stomach cancer	0.00127	0.00457	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Capecitabine—stomach cancer	0.00126	0.00454	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Docetaxel—stomach cancer	0.00125	0.00449	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Capecitabine—stomach cancer	0.00121	0.00435	CcSEcCtD
Carbinoxamine—Convulsion—Fluorouracil—stomach cancer	0.00119	0.0043	CcSEcCtD
Carbinoxamine—Agranulocytosis—Docetaxel—stomach cancer	0.00119	0.00428	CcSEcCtD
Carbinoxamine—Confusional state—Irinotecan—stomach cancer	0.00118	0.00426	CcSEcCtD
Carbinoxamine—Photosensitivity—Doxorubicin—stomach cancer	0.00117	0.00423	CcSEcCtD
Carbinoxamine—Agranulocytosis—Capecitabine—stomach cancer	0.00115	0.00414	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Irinotecan—stomach cancer	0.00115	0.00414	CcSEcCtD
Carbinoxamine—Irritability—Methotrexate—stomach cancer	0.00114	0.00409	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Irinotecan—stomach cancer	0.00113	0.00409	CcSEcCtD
Carbinoxamine—Confusional state—Fluorouracil—stomach cancer	0.00113	0.00408	CcSEcCtD
Carbinoxamine—Anorexia—Irinotecan—stomach cancer	0.00112	0.00403	CcSEcCtD
Carbinoxamine—Diplopia—Epirubicin—stomach cancer	0.00111	0.00401	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Fluorouracil—stomach cancer	0.0011	0.00396	CcSEcCtD
Carbinoxamine—Tachycardia—Fluorouracil—stomach cancer	0.0011	0.00395	CcSEcCtD
Carbinoxamine—Hypotension—Irinotecan—stomach cancer	0.0011	0.00395	CcSEcCtD
Carbinoxamine—Anorexia—Fluorouracil—stomach cancer	0.00107	0.00386	CcSEcCtD
Carbinoxamine—Insomnia—Irinotecan—stomach cancer	0.00106	0.00382	CcSEcCtD
Carbinoxamine—Paraesthesia—Irinotecan—stomach cancer	0.00105	0.0038	CcSEcCtD
Carbinoxamine—Hypotension—Fluorouracil—stomach cancer	0.00105	0.00378	CcSEcCtD
Carbinoxamine—Somnolence—Irinotecan—stomach cancer	0.00104	0.00376	CcSEcCtD
Carbinoxamine—Dyspepsia—Irinotecan—stomach cancer	0.00103	0.00372	CcSEcCtD
Carbinoxamine—Tinnitus—Capecitabine—stomach cancer	0.00103	0.00371	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—stomach cancer	0.00103	0.00371	CcSEcCtD
Carbinoxamine—Chills—Docetaxel—stomach cancer	0.00102	0.00369	CcSEcCtD
Carbinoxamine—Decreased appetite—Irinotecan—stomach cancer	0.00102	0.00367	CcSEcCtD
Carbinoxamine—Insomnia—Fluorouracil—stomach cancer	0.00102	0.00366	CcSEcCtD
Carbinoxamine—Fatigue—Irinotecan—stomach cancer	0.00101	0.00364	CcSEcCtD
Carbinoxamine—Paraesthesia—Fluorouracil—stomach cancer	0.00101	0.00364	CcSEcCtD
Carbinoxamine—Constipation—Irinotecan—stomach cancer	0.001	0.00361	CcSEcCtD
Carbinoxamine—Somnolence—Fluorouracil—stomach cancer	0.000999	0.0036	CcSEcCtD
Carbinoxamine—Chills—Capecitabine—stomach cancer	0.000992	0.00357	CcSEcCtD
Carbinoxamine—Dyspepsia—Fluorouracil—stomach cancer	0.000989	0.00356	CcSEcCtD
Carbinoxamine—Decreased appetite—Fluorouracil—stomach cancer	0.000977	0.00352	CcSEcCtD
Carbinoxamine—Feeling abnormal—Irinotecan—stomach cancer	0.000967	0.00348	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Methotrexate—stomach cancer	0.000939	0.00338	CcSEcCtD
Carbinoxamine—Feeling abnormal—Fluorouracil—stomach cancer	0.000926	0.00334	CcSEcCtD
Carbinoxamine—Drowsiness—Methotrexate—stomach cancer	0.000917	0.0033	CcSEcCtD
Carbinoxamine—Vision blurred—Capecitabine—stomach cancer	0.000907	0.00327	CcSEcCtD
Carbinoxamine—Tremor—Capecitabine—stomach cancer	0.000902	0.00325	CcSEcCtD
Carbinoxamine—Urticaria—Fluorouracil—stomach cancer	0.000893	0.00322	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—stomach cancer	0.000889	0.0032	CcSEcCtD
Carbinoxamine—Palpitations—Docetaxel—stomach cancer	0.000878	0.00316	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Epirubicin—stomach cancer	0.000878	0.00316	CcSEcCtD
Carbinoxamine—Vertigo—Capecitabine—stomach cancer	0.000865	0.00311	CcSEcCtD
Carbinoxamine—Convulsion—Docetaxel—stomach cancer	0.000861	0.0031	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—stomach cancer	0.000858	0.00309	CcSEcCtD
Carbinoxamine—Agranulocytosis—Methotrexate—stomach cancer	0.000856	0.00308	CcSEcCtD
Carbinoxamine—Palpitations—Capecitabine—stomach cancer	0.000851	0.00306	CcSEcCtD
Carbinoxamine—Asthenia—Irinotecan—stomach cancer	0.000842	0.00303	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000841	0.00303	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—stomach cancer	0.000823	0.00296	CcSEcCtD
Carbinoxamine—Confusional state—Docetaxel—stomach cancer	0.000818	0.00295	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000813	0.00293	CcSEcCtD
Carbinoxamine—Diarrhoea—Irinotecan—stomach cancer	0.000803	0.00289	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—stomach cancer	0.000801	0.00288	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Docetaxel—stomach cancer	0.000794	0.00286	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—stomach cancer	0.000794	0.00286	CcSEcCtD
Carbinoxamine—Confusional state—Capecitabine—stomach cancer	0.000792	0.00285	CcSEcCtD
Carbinoxamine—Tachycardia—Docetaxel—stomach cancer	0.000792	0.00285	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000778	0.0028	CcSEcCtD
Carbinoxamine—Dizziness—Irinotecan—stomach cancer	0.000776	0.0028	CcSEcCtD
Carbinoxamine—Anorexia—Docetaxel—stomach cancer	0.000773	0.00279	CcSEcCtD
Carbinoxamine—Diarrhoea—Fluorouracil—stomach cancer	0.000769	0.00277	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Capecitabine—stomach cancer	0.000769	0.00277	CcSEcCtD
Carbinoxamine—Chlorpromazine—HRH4—stomach cancer	0.000768	0.439	CrCbGaD
Carbinoxamine—Tinnitus—Methotrexate—stomach cancer	0.000767	0.00276	CcSEcCtD
Carbinoxamine—Tachycardia—Capecitabine—stomach cancer	0.000767	0.00276	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Capecitabine—stomach cancer	0.000759	0.00274	CcSEcCtD
Carbinoxamine—Hypotension—Docetaxel—stomach cancer	0.000758	0.00273	CcSEcCtD
Carbinoxamine—Anorexia—Capecitabine—stomach cancer	0.000749	0.0027	CcSEcCtD
Carbinoxamine—Vomiting—Irinotecan—stomach cancer	0.000746	0.00269	CcSEcCtD
Carbinoxamine—Dizziness—Fluorouracil—stomach cancer	0.000743	0.00268	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—stomach cancer	0.000741	0.00267	CcSEcCtD
Carbinoxamine—Chills—Methotrexate—stomach cancer	0.000739	0.00266	CcSEcCtD
Carbinoxamine—Headache—Irinotecan—stomach cancer	0.000735	0.00265	CcSEcCtD
Carbinoxamine—Hypotension—Capecitabine—stomach cancer	0.000734	0.00264	CcSEcCtD
Carbinoxamine—Insomnia—Docetaxel—stomach cancer	0.000734	0.00264	CcSEcCtD
Carbinoxamine—Paraesthesia—Docetaxel—stomach cancer	0.000729	0.00262	CcSEcCtD
Carbinoxamine—Somnolence—Docetaxel—stomach cancer	0.000721	0.0026	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—stomach cancer	0.000718	0.00259	CcSEcCtD
Carbinoxamine—Vomiting—Fluorouracil—stomach cancer	0.000715	0.00257	CcSEcCtD
Carbinoxamine—Dyspepsia—Docetaxel—stomach cancer	0.000714	0.00257	CcSEcCtD
Carbinoxamine—Insomnia—Capecitabine—stomach cancer	0.00071	0.00256	CcSEcCtD
Carbinoxamine—Paraesthesia—Capecitabine—stomach cancer	0.000705	0.00254	CcSEcCtD
Carbinoxamine—Decreased appetite—Docetaxel—stomach cancer	0.000705	0.00254	CcSEcCtD
Carbinoxamine—Headache—Fluorouracil—stomach cancer	0.000704	0.00254	CcSEcCtD
Carbinoxamine—Fatigue—Docetaxel—stomach cancer	0.000699	0.00252	CcSEcCtD
Carbinoxamine—Nausea—Irinotecan—stomach cancer	0.000697	0.00251	CcSEcCtD
Carbinoxamine—Constipation—Docetaxel—stomach cancer	0.000694	0.0025	CcSEcCtD
Carbinoxamine—Dyspepsia—Capecitabine—stomach cancer	0.000691	0.00249	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—stomach cancer	0.000691	0.00249	CcSEcCtD
Carbinoxamine—Decreased appetite—Capecitabine—stomach cancer	0.000683	0.00246	CcSEcCtD
Carbinoxamine—Fatigue—Capecitabine—stomach cancer	0.000677	0.00244	CcSEcCtD
Carbinoxamine—Vision blurred—Methotrexate—stomach cancer	0.000675	0.00243	CcSEcCtD
Carbinoxamine—Constipation—Capecitabine—stomach cancer	0.000672	0.00242	CcSEcCtD
Carbinoxamine—Feeling abnormal—Docetaxel—stomach cancer	0.000669	0.00241	CcSEcCtD
Carbinoxamine—Nausea—Fluorouracil—stomach cancer	0.000668	0.0024	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—stomach cancer	0.000664	0.00239	CcSEcCtD
Carbinoxamine—Tension—Epirubicin—stomach cancer	0.000658	0.00237	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—stomach cancer	0.000651	0.00235	CcSEcCtD
Carbinoxamine—Feeling abnormal—Capecitabine—stomach cancer	0.000647	0.00233	CcSEcCtD
Carbinoxamine—Vertigo—Methotrexate—stomach cancer	0.000644	0.00232	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—stomach cancer	0.000639	0.0023	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—stomach cancer	0.000632	0.00228	CcSEcCtD
Carbinoxamine—Urticaria—Capecitabine—stomach cancer	0.000624	0.00225	CcSEcCtD
Carbinoxamine—Convulsion—Methotrexate—stomach cancer	0.000621	0.00224	CcSEcCtD
Carbinoxamine—Agitation—Epirubicin—stomach cancer	0.000616	0.00222	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—stomach cancer	0.000609	0.00219	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—stomach cancer	0.000603	0.00217	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—stomach cancer	0.000602	0.00217	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—stomach cancer	0.000593	0.00213	CcSEcCtD
Carbinoxamine—Confusional state—Methotrexate—stomach cancer	0.00059	0.00212	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—stomach cancer	0.000585	0.00211	CcSEcCtD
Carbinoxamine—Asthenia—Docetaxel—stomach cancer	0.000582	0.0021	CcSEcCtD
Carbinoxamine—Convulsion—Epirubicin—stomach cancer	0.000581	0.00209	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Methotrexate—stomach cancer	0.000573	0.00206	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—stomach cancer	0.00057	0.00205	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Methotrexate—stomach cancer	0.000565	0.00204	CcSEcCtD
Carbinoxamine—Asthenia—Capecitabine—stomach cancer	0.000564	0.00203	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—stomach cancer	0.000557	0.00201	CcSEcCtD
Carbinoxamine—Anorexia—Methotrexate—stomach cancer	0.000557	0.00201	CcSEcCtD
Carbinoxamine—Diarrhoea—Docetaxel—stomach cancer	0.000555	0.002	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—stomach cancer	0.000552	0.00199	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—stomach cancer	0.000548	0.00197	CcSEcCtD
Carbinoxamine—Hypotension—Methotrexate—stomach cancer	0.000546	0.00197	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—stomach cancer	0.000538	0.00194	CcSEcCtD
Carbinoxamine—Diarrhoea—Capecitabine—stomach cancer	0.000537	0.00194	CcSEcCtD
Carbinoxamine—Dizziness—Docetaxel—stomach cancer	0.000537	0.00193	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—stomach cancer	0.000536	0.00193	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—stomach cancer	0.000534	0.00192	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—stomach cancer	0.000529	0.00191	CcSEcCtD
Carbinoxamine—Insomnia—Methotrexate—stomach cancer	0.000529	0.0019	CcSEcCtD
Carbinoxamine—Paraesthesia—Methotrexate—stomach cancer	0.000525	0.00189	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—stomach cancer	0.000522	0.00188	CcSEcCtD
Carbinoxamine—Somnolence—Methotrexate—stomach cancer	0.00052	0.00187	CcSEcCtD
Carbinoxamine—Dizziness—Capecitabine—stomach cancer	0.000519	0.00187	CcSEcCtD
Carbinoxamine—Vomiting—Docetaxel—stomach cancer	0.000516	0.00186	CcSEcCtD
Carbinoxamine—Clomipramine—GSTP1—stomach cancer	0.000516	0.294	CrCbGaD
Carbinoxamine—Dyspepsia—Methotrexate—stomach cancer	0.000515	0.00185	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—stomach cancer	0.000511	0.00184	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—stomach cancer	0.000511	0.00184	CcSEcCtD
Carbinoxamine—Decreased appetite—Methotrexate—stomach cancer	0.000508	0.00183	CcSEcCtD
Carbinoxamine—Headache—Docetaxel—stomach cancer	0.000508	0.00183	CcSEcCtD
Carbinoxamine—Fatigue—Methotrexate—stomach cancer	0.000504	0.00182	CcSEcCtD
Carbinoxamine—Vomiting—Capecitabine—stomach cancer	0.000499	0.0018	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000496	0.00179	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—stomach cancer	0.000495	0.00178	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—stomach cancer	0.000494	0.00178	CcSEcCtD
Carbinoxamine—Headache—Capecitabine—stomach cancer	0.000492	0.00177	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—stomach cancer	0.000491	0.00177	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000489	0.00176	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—stomach cancer	0.000486	0.00175	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—stomach cancer	0.000483	0.00174	CcSEcCtD
Carbinoxamine—Nausea—Docetaxel—stomach cancer	0.000482	0.00174	CcSEcCtD
Carbinoxamine—Feeling abnormal—Methotrexate—stomach cancer	0.000482	0.00174	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—stomach cancer	0.000482	0.00174	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—stomach cancer	0.000476	0.00171	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—stomach cancer	0.000473	0.0017	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—stomach cancer	0.000472	0.0017	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—stomach cancer	0.000468	0.00169	CcSEcCtD
Carbinoxamine—Nausea—Capecitabine—stomach cancer	0.000467	0.00168	CcSEcCtD
Carbinoxamine—Urticaria—Methotrexate—stomach cancer	0.000465	0.00167	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—stomach cancer	0.000458	0.00165	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—stomach cancer	0.000455	0.00164	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—stomach cancer	0.000451	0.00162	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—stomach cancer	0.00045	0.00162	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—stomach cancer	0.000446	0.00161	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—stomach cancer	0.00044	0.00159	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—stomach cancer	0.000437	0.00157	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—stomach cancer	0.000435	0.00157	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—stomach cancer	0.000433	0.00156	CcSEcCtD
Carbinoxamine—Asthenia—Methotrexate—stomach cancer	0.00042	0.00151	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—stomach cancer	0.000417	0.0015	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—stomach cancer	0.000402	0.00145	CcSEcCtD
Carbinoxamine—Diarrhoea—Methotrexate—stomach cancer	0.0004	0.00144	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—stomach cancer	0.000393	0.00141	CcSEcCtD
Carbinoxamine—Dizziness—Methotrexate—stomach cancer	0.000387	0.00139	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—stomach cancer	0.000374	0.00135	CcSEcCtD
Carbinoxamine—Vomiting—Methotrexate—stomach cancer	0.000372	0.00134	CcSEcCtD
Carbinoxamine—Headache—Methotrexate—stomach cancer	0.000366	0.00132	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—stomach cancer	0.000363	0.00131	CcSEcCtD
Carbinoxamine—Dizziness—Epirubicin—stomach cancer	0.000362	0.0013	CcSEcCtD
Carbinoxamine—Vomiting—Epirubicin—stomach cancer	0.000348	0.00125	CcSEcCtD
Carbinoxamine—Nausea—Methotrexate—stomach cancer	0.000347	0.00125	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—stomach cancer	0.000346	0.00125	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—stomach cancer	0.000343	0.00123	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—stomach cancer	0.000335	0.00121	CcSEcCtD
Carbinoxamine—Nausea—Epirubicin—stomach cancer	0.000325	0.00117	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—stomach cancer	0.000322	0.00116	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—stomach cancer	0.000317	0.00114	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—stomach cancer	0.000301	0.00108	CcSEcCtD
Carbinoxamine—Chlorpromazine—HTR1A—stomach cancer	0.000222	0.127	CrCbGaD
Carbinoxamine—Clomipramine—ALB—stomach cancer	0.000145	0.083	CrCbGaD
Carbinoxamine—CYP2C19—hematopoietic system—stomach cancer	0.000129	0.0533	CbGeAlD
Carbinoxamine—CYP2C8—hematopoietic system—stomach cancer	0.000113	0.0465	CbGeAlD
Carbinoxamine—CYP2B6—hematopoietic system—stomach cancer	0.000101	0.0417	CbGeAlD
Carbinoxamine—CYP2C9—hematopoietic system—stomach cancer	0.0001	0.0413	CbGeAlD
Carbinoxamine—Chlorpromazine—ALB—stomach cancer	9.97e-05	0.0569	CrCbGaD
Carbinoxamine—HRH1—hematopoietic system—stomach cancer	9.87e-05	0.0408	CbGeAlD
Carbinoxamine—CYP2E1—hematopoietic system—stomach cancer	9.48e-05	0.0392	CbGeAlD
Carbinoxamine—HRH1—epithelium—stomach cancer	9.02e-05	0.0373	CbGeAlD
Carbinoxamine—CYP2C19—digestive system—stomach cancer	8.98e-05	0.0371	CbGeAlD
Carbinoxamine—HRH1—smooth muscle tissue—stomach cancer	8.69e-05	0.0359	CbGeAlD
Carbinoxamine—CYP3A4—hematopoietic system—stomach cancer	7.63e-05	0.0315	CbGeAlD
Carbinoxamine—CYP2D6—hematopoietic system—stomach cancer	7.51e-05	0.031	CbGeAlD
Carbinoxamine—CYP2C19—endocrine gland—stomach cancer	7.42e-05	0.0306	CbGeAlD
Carbinoxamine—CYP2B6—lymphoid tissue—stomach cancer	7.11e-05	0.0294	CbGeAlD
Carbinoxamine—CYP2B6—digestive system—stomach cancer	7.03e-05	0.029	CbGeAlD
Carbinoxamine—CYP2C9—digestive system—stomach cancer	6.96e-05	0.0287	CbGeAlD
Carbinoxamine—HRH1—digestive system—stomach cancer	6.86e-05	0.0283	CbGeAlD
Carbinoxamine—CYP2C19—liver—stomach cancer	6.69e-05	0.0276	CbGeAlD
Carbinoxamine—CYP2E1—lymphoid tissue—stomach cancer	6.68e-05	0.0276	CbGeAlD
Carbinoxamine—CYP2E1—digestive system—stomach cancer	6.6e-05	0.0272	CbGeAlD
Carbinoxamine—CYP2C8—endocrine gland—stomach cancer	6.47e-05	0.0267	CbGeAlD
Carbinoxamine—CYP2C8—liver—stomach cancer	5.84e-05	0.0241	CbGeAlD
Carbinoxamine—CYP2B6—endocrine gland—stomach cancer	5.81e-05	0.024	CbGeAlD
Carbinoxamine—CYP2C9—endocrine gland—stomach cancer	5.75e-05	0.0237	CbGeAlD
Carbinoxamine—HRH1—endocrine gland—stomach cancer	5.67e-05	0.0234	CbGeAlD
Carbinoxamine—CYP2E1—endocrine gland—stomach cancer	5.45e-05	0.0225	CbGeAlD
Carbinoxamine—CYP3A4—digestive system—stomach cancer	5.31e-05	0.0219	CbGeAlD
Carbinoxamine—CYP2B6—liver—stomach cancer	5.24e-05	0.0216	CbGeAlD
Carbinoxamine—CYP2D6—digestive system—stomach cancer	5.22e-05	0.0216	CbGeAlD
Carbinoxamine—CYP2C9—liver—stomach cancer	5.18e-05	0.0214	CbGeAlD
Carbinoxamine—CYP2E1—liver—stomach cancer	4.91e-05	0.0203	CbGeAlD
Carbinoxamine—CYP3A4—endocrine gland—stomach cancer	4.38e-05	0.0181	CbGeAlD
Carbinoxamine—CYP2D6—endocrine gland—stomach cancer	4.31e-05	0.0178	CbGeAlD
Carbinoxamine—CYP3A4—liver—stomach cancer	3.95e-05	0.0163	CbGeAlD
Carbinoxamine—HRH1—lymph node—stomach cancer	3.92e-05	0.0162	CbGeAlD
Carbinoxamine—CYP2D6—liver—stomach cancer	3.89e-05	0.0161	CbGeAlD
Carbinoxamine—CYP2C19—Metabolism—RORA—stomach cancer	3.56e-05	0.000313	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TYMP—stomach cancer	3.54e-05	0.000311	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—FADS1—stomach cancer	3.54e-05	0.000311	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP2A6—stomach cancer	3.53e-05	0.00031	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.53e-05	0.000309	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.52e-05	0.000309	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TYMP—stomach cancer	3.51e-05	0.000308	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—FADS1—stomach cancer	3.51e-05	0.000308	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTT1—stomach cancer	3.5e-05	0.000307	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALOX5—stomach cancer	3.48e-05	0.000305	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP2A6—stomach cancer	3.46e-05	0.000304	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AGTR2—stomach cancer	3.46e-05	0.000303	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HSPB1—stomach cancer	3.46e-05	0.000303	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKR1C3—stomach cancer	3.44e-05	0.000301	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—DPYD—stomach cancer	3.42e-05	0.0003	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—F2R—stomach cancer	3.42e-05	0.0003	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BMP2—stomach cancer	3.42e-05	0.0003	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKR1C3—stomach cancer	3.37e-05	0.000295	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKR1C3—stomach cancer	3.36e-05	0.000295	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ENO1—stomach cancer	3.35e-05	0.000294	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALDOB—stomach cancer	3.34e-05	0.000293	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HTR1A—stomach cancer	3.33e-05	0.000292	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SREBF2—stomach cancer	3.32e-05	0.000291	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SREBF2—stomach cancer	3.29e-05	0.000288	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ENO1—stomach cancer	3.28e-05	0.000288	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—RORA—stomach cancer	3.28e-05	0.000287	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.25e-05	0.000285	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FBP1—stomach cancer	3.25e-05	0.000285	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CA1—stomach cancer	3.25e-05	0.000285	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CKB—stomach cancer	3.25e-05	0.000285	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—RORA—stomach cancer	3.25e-05	0.000285	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PRKCB—stomach cancer	3.22e-05	0.000283	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ANXA1—stomach cancer	3.21e-05	0.000282	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.15e-05	0.000276	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.14e-05	0.000276	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADRB1—stomach cancer	3.11e-05	0.000273	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALOX5—stomach cancer	3.11e-05	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.1e-05	0.000272	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALDOB—stomach cancer	3.07e-05	0.000269	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLIN2—stomach cancer	3.06e-05	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—DPYD—stomach cancer	3.05e-05	0.000268	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALDOB—stomach cancer	3.05e-05	0.000267	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTT1—stomach cancer	3.03e-05	0.000265	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP2A6—stomach cancer	2.99e-05	0.000262	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CA2—stomach cancer	2.97e-05	0.000261	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RPS6—stomach cancer	2.97e-05	0.000261	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CD44—stomach cancer	2.97e-05	0.000261	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PRKCB—stomach cancer	2.93e-05	0.000257	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6ST—stomach cancer	2.91e-05	0.000256	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKR1C3—stomach cancer	2.91e-05	0.000255	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CD44—stomach cancer	2.91e-05	0.000255	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PGAM1—stomach cancer	2.9e-05	0.000254	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NT5E—stomach cancer	2.9e-05	0.000254	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.87e-05	0.000252	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.87e-05	0.000251	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALOX5—stomach cancer	2.86e-05	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ENO1—stomach cancer	2.84e-05	0.000249	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALOX5—stomach cancer	2.83e-05	0.000248	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—DPYD—stomach cancer	2.81e-05	0.000246	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.79e-05	0.000245	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—DPYD—stomach cancer	2.79e-05	0.000244	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.77e-05	0.000243	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLCE1—stomach cancer	2.76e-05	0.000242	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.76e-05	0.000242	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HBEGF—stomach cancer	2.73e-05	0.00024	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTT1—stomach cancer	2.7e-05	0.000237	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP2A6—stomach cancer	2.67e-05	0.000234	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—UMPS—stomach cancer	2.65e-05	0.000232	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6R—stomach cancer	2.6e-05	0.000228	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKR1C3—stomach cancer	2.6e-05	0.000228	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—RHOA—stomach cancer	2.59e-05	0.000227	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ENO1—stomach cancer	2.53e-05	0.000222	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPP2R1A—stomach cancer	2.53e-05	0.000222	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.52e-05	0.000221	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ADRB2—stomach cancer	2.52e-05	0.000221	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CD44—stomach cancer	2.52e-05	0.000221	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.49e-05	0.000218	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTT1—stomach cancer	2.48e-05	0.000218	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTP1—stomach cancer	2.48e-05	0.000217	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPP2R1A—stomach cancer	2.47e-05	0.000217	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	2.47e-05	0.000217	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PDHA1—stomach cancer	2.46e-05	0.000216	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ECHS1—stomach cancer	2.46e-05	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTT1—stomach cancer	2.46e-05	0.000216	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP2A6—stomach cancer	2.46e-05	0.000215	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—HMOX1—stomach cancer	2.44e-05	0.000214	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.44e-05	0.000214	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP2A6—stomach cancer	2.43e-05	0.000214	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTP1—stomach cancer	2.43e-05	0.000213	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—HMOX1—stomach cancer	2.39e-05	0.00021	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKR1C3—stomach cancer	2.39e-05	0.00021	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKR1C3—stomach cancer	2.37e-05	0.000208	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—RHOA—stomach cancer	2.35e-05	0.000206	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ENO1—stomach cancer	2.33e-05	0.000204	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TYMP—stomach cancer	2.32e-05	0.000203	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FADS1—stomach cancer	2.32e-05	0.000203	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ENO1—stomach cancer	2.31e-05	0.000202	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—TYMS—stomach cancer	2.3e-05	0.000202	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SMAD4—stomach cancer	2.29e-05	0.000201	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GSTM1—stomach cancer	2.28e-05	0.0002	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	2.27e-05	0.000199	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.27e-05	0.000199	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—TYMS—stomach cancer	2.26e-05	0.000198	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CD44—stomach cancer	2.25e-05	0.000197	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GSTM1—stomach cancer	2.23e-05	0.000196	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FYN—stomach cancer	2.18e-05	0.000191	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.18e-05	0.000191	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SREBF2—stomach cancer	2.17e-05	0.00019	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—RORA—stomach cancer	2.14e-05	0.000188	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ERCC2—stomach cancer	2.14e-05	0.000188	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPP2R1A—stomach cancer	2.14e-05	0.000188	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTP1—stomach cancer	2.1e-05	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ERCC2—stomach cancer	2.1e-05	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—HMOX1—stomach cancer	2.07e-05	0.000181	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CD44—stomach cancer	2.06e-05	0.000181	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	2.06e-05	0.000181	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CD44—stomach cancer	2.05e-05	0.00018	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGFR2—stomach cancer	2.05e-05	0.000179	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—MTHFR—stomach cancer	2.01e-05	0.000176	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALDOB—stomach cancer	2.01e-05	0.000176	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.99e-05	0.000174	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—MTHFR—stomach cancer	1.97e-05	0.000173	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—TYMS—stomach cancer	1.95e-05	0.000171	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GSTM1—stomach cancer	1.93e-05	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.91e-05	0.000167	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS2—stomach cancer	1.87e-05	0.000164	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTP1—stomach cancer	1.87e-05	0.000164	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALOX5—stomach cancer	1.87e-05	0.000164	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CAV1—stomach cancer	1.86e-05	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—APOA1—stomach cancer	1.85e-05	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—HMOX1—stomach cancer	1.85e-05	0.000162	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—DPYD—stomach cancer	1.84e-05	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CAV1—stomach cancer	1.82e-05	0.000159	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CAV1—stomach cancer	1.82e-05	0.000159	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—APOA1—stomach cancer	1.81e-05	0.000159	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ERCC2—stomach cancer	1.81e-05	0.000159	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APOA1—stomach cancer	1.81e-05	0.000159	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.76e-05	0.000154	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—TYMS—stomach cancer	1.74e-05	0.000153	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.74e-05	0.000153	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCB—stomach cancer	1.73e-05	0.000152	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTP1—stomach cancer	1.72e-05	0.000151	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6ST—stomach cancer	1.72e-05	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GSTM1—stomach cancer	1.72e-05	0.000151	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTP1—stomach cancer	1.71e-05	0.00015	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—MTHFR—stomach cancer	1.7e-05	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—HMOX1—stomach cancer	1.7e-05	0.000149	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—HMOX1—stomach cancer	1.68e-05	0.000148	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APC—stomach cancer	1.65e-05	0.000145	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—stomach cancer	1.63e-05	0.000143	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTT1—stomach cancer	1.62e-05	0.000142	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ERCC2—stomach cancer	1.62e-05	0.000142	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.61e-05	0.000141	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—TYMS—stomach cancer	1.6e-05	0.00014	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—stomach cancer	1.6e-05	0.00014	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—TYMS—stomach cancer	1.59e-05	0.000139	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	1.58e-05	0.000139	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GSTM1—stomach cancer	1.58e-05	0.000139	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CAV1—stomach cancer	1.57e-05	0.000138	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GSTM1—stomach cancer	1.57e-05	0.000138	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—APOA1—stomach cancer	1.57e-05	0.000137	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.56e-05	0.000137	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6R—stomach cancer	1.54e-05	0.000135	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ENO1—stomach cancer	1.52e-05	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—MTHFR—stomach cancer	1.52e-05	0.000133	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	1.51e-05	0.000132	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EGFR—stomach cancer	1.51e-05	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.5e-05	0.000132	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ERCC2—stomach cancer	1.49e-05	0.00013	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ERCC2—stomach cancer	1.48e-05	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—stomach cancer	1.47e-05	0.000129	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	1.44e-05	0.000126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	1.44e-05	0.000126	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—stomach cancer	1.44e-05	0.000126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—KRAS—stomach cancer	1.42e-05	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—NOS3—stomach cancer	1.4e-05	0.000123	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CAV1—stomach cancer	1.4e-05	0.000123	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—APOA1—stomach cancer	1.4e-05	0.000123	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—MTHFR—stomach cancer	1.4e-05	0.000123	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RHOA—stomach cancer	1.39e-05	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—MTHFR—stomach cancer	1.39e-05	0.000122	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—stomach cancer	1.38e-05	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—NOS3—stomach cancer	1.37e-05	0.000121	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOS3—stomach cancer	1.37e-05	0.00012	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CD44—stomach cancer	1.35e-05	0.000118	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.34e-05	0.000118	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	1.31e-05	0.000115	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CAV1—stomach cancer	1.29e-05	0.000113	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—APOA1—stomach cancer	1.29e-05	0.000113	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB2—stomach cancer	1.28e-05	0.000113	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—stomach cancer	1.28e-05	0.000113	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CAV1—stomach cancer	1.28e-05	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—APOA1—stomach cancer	1.28e-05	0.000112	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—stomach cancer	1.26e-05	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—stomach cancer	1.24e-05	0.000109	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—stomach cancer	1.23e-05	0.000108	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.22e-05	0.000107	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL8—stomach cancer	1.22e-05	0.000107	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HRAS—stomach cancer	1.21e-05	0.000106	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	1.19e-05	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—NOS3—stomach cancer	1.19e-05	0.000104	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—stomach cancer	1.16e-05	0.000102	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.15e-05	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—stomach cancer	1.13e-05	9.95e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—stomach cancer	1.13e-05	9.95e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—JUN—stomach cancer	1.13e-05	9.93e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTP1—stomach cancer	1.13e-05	9.87e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—stomach cancer	1.12e-05	9.86e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HMOX1—stomach cancer	1.11e-05	9.74e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—stomach cancer	1.11e-05	9.72e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—stomach cancer	1.1e-05	9.66e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	1.1e-05	9.63e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—stomach cancer	1.09e-05	9.53e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK8—stomach cancer	1.07e-05	9.39e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—NOS3—stomach cancer	1.06e-05	9.3e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—TYMS—stomach cancer	1.05e-05	9.18e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GSTM1—stomach cancer	1.03e-05	9.07e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—stomach cancer	1.02e-05	8.94e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—stomach cancer	1.01e-05	8.87e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—stomach cancer	9.89e-06	8.67e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—stomach cancer	9.79e-06	8.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—NOS3—stomach cancer	9.76e-06	8.55e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ERCC2—stomach cancer	9.73e-06	8.53e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—stomach cancer	9.7e-06	8.51e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—NOS3—stomach cancer	9.67e-06	8.48e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK3—stomach cancer	9.36e-06	8.21e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTHFR—stomach cancer	9.14e-06	8.02e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—stomach cancer	9.1e-06	7.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—stomach cancer	8.92e-06	7.82e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK1—stomach cancer	8.9e-06	7.81e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGFR—stomach cancer	8.9e-06	7.81e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—stomach cancer	8.85e-06	7.76e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CAV1—stomach cancer	8.43e-06	7.4e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—APOA1—stomach cancer	8.42e-06	7.38e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KRAS—stomach cancer	8.41e-06	7.37e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—stomach cancer	7.9e-06	6.93e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—stomach cancer	7.74e-06	6.78e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	7.73e-06	6.77e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—stomach cancer	7.47e-06	6.55e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—stomach cancer	7.42e-06	6.5e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HRAS—stomach cancer	7.15e-06	6.27e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—stomach cancer	6.84e-06	6e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—stomach cancer	6.69e-06	5.86e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—stomach cancer	6.67e-06	5.85e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—NOS3—stomach cancer	6.38e-06	5.59e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—stomach cancer	5.97e-06	5.23e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—stomach cancer	5.83e-06	5.12e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—stomach cancer	5.49e-06	4.81e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—stomach cancer	5.44e-06	4.77e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.59e-06	3.15e-05	CbGpPWpGaD
